OncoSil Medical Limited (ASX: OSL) Non-Executive Director Brian Leedman discusses joining the board of OncoSil and receiving CE mark approval for the company’s therapy.
OncoSil Medical (ASX: OSL) – Targeted therapy for pancreatic cancer
OncoSil Medical Limited Non-Executive Director Brian Leedman discusses joining the board of OncoSil and receiving CE mark approval for the company's therapy.
- Published on November 15, 2022
- By Finance News Network
Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X
Recent Posts
- Gold Prices Surge Amidst Economic UncertaintyJanuary 23, 2025
- Goldman Sachs Announces Major Leadership ReshuffleJanuary 23, 2025
- TD Bank Sells Off Loans to Meet Regulatory CapJanuary 23, 2025
- Wall Street Embraces AI: Automation, Decision-Making,...January 22, 2025
- Brevan Howard Cuts Hedge Fund Trading WorkforceJanuary 22, 2025
All Categories
- Battery Technology (2)
- Biotechnology (101)
- brekkie wrap (38)
- Broker News (2466)
- Commodities (1680)
- Hydrogen (6)
- Lithium (106)
- Potash (11)
- Rare Earths (6)
- Renewables (35)
- Company (7)
- Corporate Connect Research (24)
- Currencies (42)
- Cryptocurrencies (28)
- daily special (41)
- David Bassanese (90)
- Economics (3084)
- ESG (117)
- Etfs (500)
- EV Space (128)
- Featured (11)
- FinTech (26)
- Fixed Interest (231)
- FNN Content (6112)
- Franklin Templeton (1)
- fresh grind (10)
- fundie guide (21)
- Funds (1422)
- Gavin Wendt (141)
- Greg Tolpigin (75)
- hot stocks (28)
- Infrastructure (28)
- Interest Rates (386)
- investor blend (30)
- IPOs (20)
- James Dunn (185)
- Kris Walesby (67)
- LICs (162)
- Marc Sinatra (4)
- market mocha (106)
- Market Reports Text (283)
- Markets (14003)
- Media (71)
- Noosa Mining Conference (29)
- Podcasts (1)
- Politics (53)
- Product Profiles (23)
- Property (225)
- Reports (511)
- Retail (254)
- round table (8)
- Shane Oliver (260)
- Shares (18215)
- Stocks of the Hour (300)
- sip & learn (20)
- sip and learn (20)
- Sponsored Content (32)
- Strategy (204)
- Super (36)
- table for two (13)
- Technical Analysis (5)
- Technology (419)
- The Week that Was (112)
- Tim Boreham (85)
- Uncategorized (157)
- Video (4332)
- Webinars (195)
- Weekly Wrap (826)